|

Registry Platform Gastric/Esophageal Cancer (SAPHIR)

RECRUITINGSponsored by iOMEDICO AG
Actively Recruiting
SponsoriOMEDICO AG
Started2019-12-04
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04290806

Summary

The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic esophageal, gastric or gastroesophageal junction cancer, treated in palliative intention in daily routine practice in Germany.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Histologically proven stage IV (metastatic) ESCC, EAC, GAC or GEJAC
* Planned palliative systemic first-line therapy
* Age \>= 18 years
* Signed informed consent (IC)

  * Patients answering questionnaires: IC before first therapy cycle
  * Patients not answering questionnaires: IC latest 4 weeks after start of first therapy cycle

Exclusion Criteria:

* No systemic therapy for ESCC, EAC, GAC or GEJAC

Conditions5

CancerEsophageal AdenocarcinomaEsophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.